Literature DB >> 19138975

Assessing efficacy in early-phase cancer prevention trials: the case of oral premalignancy.

Eva Szabo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19138975     DOI： 10.1158/1940-6207.CAPR-08-0171

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN： 1940-6215


× No keyword cloud information.
  4 in total

1.  Kava, a tonic for relieving the irrational development of natural preventive agents.

Authors:  Rajesh Agarwal; Gagan Deep
Journal:  Cancer Prev Res (Phila)       Date:  2008-11

Review 2.  Retinoid chemoprevention trials: cyclin D1 in the crosshairs.

Authors:  Sarah J Freemantle; Yongli Guo; Ethan Dmitrovsky
Journal:  Cancer Prev Res (Phila)       Date:  2009-01

3.  A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia.

Authors:  Stuart J Wong; Bruce Campbell; Becky Massey; Denis P Lynch; Ezra E W Cohen; Elizabeth Blair; Rebecca Selle; Julia Shklovskaya; Borko D Jovanovic; Silvia Skripkauskas; Alexander Dew; Peter Kulesza; Vamsi Parimi; Raymond C Bergan; Eva Szabo
Journal:  Oral Oncol       Date:  2013-07-08       Impact factor: 5.337

Review 4.  Assessing efficacy in early-phase cancer prevention clinical trials: the case of ki-67 in the lung.

Authors:  Eva Szabo
Journal:  Cancer Prev Res (Phila)       Date:  2010-01-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.